For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

Eli Lilly’s experimental insulin that is injected just once a week is as effective as daily insulin injections for ...

A research team has found that lateral septum (LS) neurons play a crucial role in the anorectic and weight-lowering effects of liraglutide in mice, revealing that GLP-1 receptors in the LS mediate ...

b.i.d.: Twice daily; LEAD: Liraglutide Effect and Action Diabetes ... for the 'incretin effect', a phenomenon in which where more insulin is secreted in response to glucose ingested during ...

Novo Nordisk’s GLP-1 agonist Victoza has become the first non-insulin drug to be approved in the US as a treatment for type 2 diabetes in children for almost two decades. The FDA says the okay ...

compared with 61.3% of time within the target range for people taking insulin degludec. In both of the new trials, efsitora's overall safety and tolerability was similar to daily basal insulins ...

Insulin can be a critical part of managing diabetes, but patients may not know all the ins and outs of using the medication effectively. Luckily, the American Diabetes Association (ADA) has plenty ...

“While further research is needed, liraglutide may work through various mechanisms, such as reducing inflammation in the brain, lowering insulin resistance and the toxic effects of Alzheimer’s ...

They can help you determine whether a different GLP-1 agonist medication like Ozempic, Victoza, or Trulicity ... 29 lb more than participants on insulin degludec 27 lb more than participants ...

We are aware of reports regarding supply issues of insulin in the UK. Here’s the latest information on how your treatment may be impacted.